Published in Arch Ophthalmol on August 01, 1980
Treatment of juxtapapillary melanomas. Br J Ophthalmol (1991) 1.11
Improved iodine-125 plaque design in the treatment of choroidal malignant melanoma. Br J Ophthalmol (1992) 0.81
Radioactive iodine-125 as a therapeutic radiation source for management of intraocular tumors. Trans Am Ophthalmol Soc (1981) 0.77
Magnetic resonance imaging of juxtapapillary plaques in cadaver eyes. Br J Ophthalmol (1990) 0.75
Adaptive replanning intensity-modulated radiotherapy for choroidal metastasis of breast cancer using optical coherence tomography. J Radiat Res (2014) 0.75
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96
Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys (1997) 8.58
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst (1993) 7.87
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med (1999) 7.56
Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell (1990) 5.06
Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Int J Radiat Oncol Biol Phys (1995) 3.86
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J (2000) 3.81
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol (2003) 3.73
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database. Nucleic Acids Res (1999) 3.44
Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int J Radiat Oncol Biol Phys (1995) 3.32
Epidemiologic aspects of uveal melanoma. Surv Ophthalmol (1988) 2.85
Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol (2001) 2.85
Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol (2001) 2.75
Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet (1994) 2.73
The ARF1 GTPase-activating protein: zinc finger motif and Golgi complex localization. Science (1995) 2.72
Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR. J Biol Chem (1999) 2.65
Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol (1983) 2.65
Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J (1994) 2.57
Homozygosity of chromosome 13 in retinoblastoma. N Engl J Med (1984) 2.49
Pinhole SPECT: an approach to in vivo high resolution SPECT imaging in small laboratory animals. J Nucl Med (1994) 2.42
Tumor metastasis to the eye. I. Incidence in 213 adult patients with generalized malignancy. Am J Ophthalmol (1967) 2.22
Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet (1994) 2.12
Effect of population-based interventions on laboratory utilization: a time-series analysis. JAMA (1998) 2.09
Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16. Ophthalmology (2001) 2.09
Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst (1974) 2.05
A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med (1980) 2.01
Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913--1978). Ophthalmology (1980) 2.00
Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys (1993) 1.99
Evolution and replacement of Candida albicans strains during recurrent vaginitis demonstrated by DNA fingerprinting. J Clin Microbiol (1994) 1.99
Retrograde transport from the yeast Golgi is mediated by two ARF GAP proteins with overlapping function. EMBO J (1999) 1.97
Primary adenocarcinoma of the lacrimal gland. A retrospective study. Ophthalmology (1993) 1.93
TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat Immunol (2001) 1.92
Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev (1994) 1.91
Retinal manifestations of neurofibromatosis. Diagnosis and management. Arch Ophthalmol (1991) 1.88
Thrombocytopenia, anemia, and retinal hemorrhage. Am J Ophthalmol (1968) 1.88
Genetic similarity of Candida albicans strains from vaginitis patients and their partners. J Clin Microbiol (1993) 1.85
Retinoblastoma in transgenic mice. Nature (1990) 1.84
Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med (1998) 1.76
Treatment choice and quality of life in patients with choroidal melanoma. Arch Ophthalmol (1999) 1.68
A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol (1983) 1.67
Therapy of experimental herpes simplex encephalitis with aciclovir in mice. Antimicrob Agents Chemother (1979) 1.65
Intraocular neurilemmoma arising from the posterior ciliary nerve in neurofibromatosis. Pathologic findings. Ophthalmology (1988) 1.63
Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol (1990) 1.62
Electron microscopy of magnesium-depleted bacteria. J Bacteriol (1966) 1.60
Intravitreous silicone injection. Histopathologic findings in a human eye after 12 years. Arch Ophthalmol (1983) 1.58
Saccharomyces cerevisiae Gcs1 is an ADP-ribosylation factor GTPase-activating protein. Proc Natl Acad Sci U S A (1996) 1.57
Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest (1994) 1.56
Appropriateness of primary total hip and knee replacements in regions of Ontario with high and low utilization rates. CMAJ (1996) 1.56
Vitrectomy retinotomy aspiration biopsy of choroidal tumors. Am J Ophthalmol (1990) 1.55
Ocular and associated systemic findings in suspected child abuse. A necropsy study. Arch Ophthalmol (1990) 1.55
Limitations of xylose tolerance test as a screening procedure in childhood coeliac disease. Arch Dis Child (1975) 1.53
RTOG's first quality of life study--RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys (1995) 1.52
Uveal malignant melanoma associated with ocular and oculodermal melanocytosis. Ophthalmology (1982) 1.51
Cell surface glypicans are low-affinity endostatin receptors. Mol Cell (2001) 1.51
Direct-to-consumer drug marketing: public service or disservice? Mt Sinai J Med (2001) 1.51
Current status of 10B-neutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: a theoretical evaluation. Int J Radiat Oncol Biol Phys (1985) 1.51
Frequency of ocular metastases in patients dying of cancer in eye bank populations. Br J Ophthalmol (1996) 1.46
Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys (1995) 1.46
Sudden visual loss associated with clostridial bacteraemia. Br J Ophthalmol (1988) 1.46
Branchial anomalies in children. Int J Pediatr Otorhinolaryngol (2011) 1.46
Mutations that reduce expression from the P2 promoter of the Escherichia coli galactose operon. Gene (1986) 1.45
A clinical and follow-up study of right and left bundle branch block. Circulation (1975) 1.43
Primary orbital Ewing sarcoma in a middle-aged woman. Arch Ophthalmol (1999) 1.43
Surgical aspects of paediatric cochlear implantation. J Laryngol Otol (1997) 1.42
Ethics and medical patents. Arch Ophthalmol (1999) 1.42
Alterations in the binding site of the cyclic AMP receptor protein at the Escherichia coli galactose operon regulatory region. Biochem J (1988) 1.40
Techniques in the radiation treatment of carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys (1991) 1.39
Oregon's health care rationing plan. Committee on Bioethical Issues of the Medical Society of the State of New York. J Gen Intern Med (1996) 1.39
RNA polymerase makes important contacts upstream from base pair -49 at the Escherichia coli galactose operon P1 promoter. Gene (1987) 1.38
Medical ethics and the excimer laser. Arch Ophthalmol (1997) 1.38
Impaired permeability in radiation-induced lung injury detected by technetium-99m-DTPA lung clearance. J Nucl Med (1997) 1.38
Subglottic haemangioma in children: experience with open surgical excision. J Laryngol Otol (2006) 1.38
Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed (1995) 1.37
Absolute and relative deficit in total-skeletal calcium and radial bone mineral in osteoporosis. J Nucl Med (1974) 1.35
Radiation therapy quality control in a clinical trial of adjuvant postoperative treatment for rectal cancer. Int J Radiat Oncol Biol Phys (1995) 1.35
Characterisation of ocular melanoma with cutaneous melanoma antibodies. Br J Ophthalmol (1987) 1.35
The financial performance of hospitals belonging to health networks and systems. Inquiry (2000) 1.34
p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch Ophthalmol (1999) 1.34
Traumatic ventricular septal defect secondary to nonpenetrating chest trauma. Am J Med (1970) 1.33
The economic cost of musculoskeletal disorders in Canada. Arthritis Care Res (1998) 1.33
Primary glaucoma associated with iridotrabecular dysgenesis and ectropion uveae. Ophthalmology (1985) 1.32
Functional analysis of different sequence elements in the Escherichia coli galactose operon P2 promoter. Mol Microbiol (1988) 1.32
Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin (1982) 1.32
Human albinism. Light and electron microscopy study. Arch Ophthalmol (1978) 1.31
Comparison of promoter activities in Escherichia coli and Pseudomonas aeruginosa: use of a new broad-host-range promoter-probe plasmid. FEMS Microbiol Lett (1990) 1.31
Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28. Int J Radiat Oncol Biol Phys (1993) 1.30
Evaluation of 99m Tc-DTPA for the measurement of glomerular filtration rate. J Nucl Med (1972) 1.30
Cellular infiltrate of the jejunum after re-introduction of dietary gluten in children with treated coeliac disease. J Clin Pathol (1976) 1.28
Ocular clinical findings and basement membrane changes in Goodpasture's syndrome. Am J Ophthalmol (1975) 1.28
Central retinal vascular occlusion associated with oral contraceptives. Am J Ophthalmol (1978) 1.26
Crystallization with hapten of the Fab' fragment from a mouse IgA myeloma protein with antidinitrophenyl activity. J Biol Chem (1971) 1.24
Urinary outputs of oxalate, calcium, and magnesium in children with intestinal disorders. Potential cause of renal calculi. Arch Dis Child (1976) 1.24
Intraocular nocardiosis. Am J Ophthalmol (1973) 1.23
Role of coatomer and phospholipids in GTPase-activating protein-dependent hydrolysis of GTP by ADP-ribosylation factor-1. J Biol Chem (2000) 1.23
Retinal light toxicity. Eye (Lond) (2010) 1.22